Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,869,000 | +11.8% | 114,454 | 0.0% | 3.88% | +38.3% |
| Q1 2021 | $3,461,000 | -39.2% | 114,454 | -0.4% | 2.80% | -35.3% |
| Q4 2020 | $5,692,000 | +20.5% | 114,962 | -6.6% | 4.34% | +16.4% |
| Q3 2020 | $4,723,000 | -11.1% | 123,025 | 0.0% | 3.73% | +0.2% |
| Q2 2020 | $5,315,000 | +20.4% | 123,025 | -28.4% | 3.72% | -14.3% |
| Q1 2020 | $4,413,000 | -24.4% | 171,788 | -8.0% | 4.34% | +11.0% |
| Q4 2019 | $5,836,000 | – | 186,749 | – | 3.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |